Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial.
about
Acromegaly pathogenesis and treatmentClinical importance of achieving biochemical control with medical therapy in adult patients with acromegalyThe effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegalyPlace of preoperative treatment of acromegaly with somatostatin analog on surgical outcome: a systematic review and meta-analysisEffectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naïve patients with acromegaly.The endocrine tumor summit 2008: appraising therapeutic approaches for acromegaly and carcinoid syndrome.Clinical experiences and success rates of acromegaly treatment: the single center results of 62 patients.Results of endoscopic transsphenoidal pituitary surgery in 40 patients with a growth hormone-secreting macroadenomaMedical therapy of acromegalyMedical management of functioning pituitary adenoma: an update.Predictors of endoscopic transsphenoidal surgery outcome in acromegaly: patient and tumor characteristics evaluated by magnetic resonance imagingFrom somatostatin to octreotide LAR: evolution of a somatostatin analogueA consensus on the diagnosis and treatment of acromegaly complications.The role of primary pharmacological therapy in acromegaly.Octreotide LAR: safety and tolerability issues.Pharmacokinetic evaluation of lanreotide.Medical therapy of acromegaly in Turkey.Medical therapy in acromegaly.Improvement of cardiac parameters in patients with acromegaly treated with medical therapies.Acromegaly surgery in Manchester revisited--the impact of reducing surgeon numbers and the 2010 consensus guidelines for disease remission.Safety review: dose optimization of somatostatin analogs in patients with acromegaly and neuroendocrine tumors.Octreotide long-acting repeatable for acromegaly.The place of medical treatment of acromegaly: current status and perspectives.Octreotide for acromegaly treatment: a reappraisal.Update on prognostic factors in acromegaly: Is a risk score possible?Should all patients with acromegaly receive somatostatin analogue therapy before surgery and, if so, for how long?Preoperative somatostatin analogues versus direct transsphenoidal surgery for newly-diagnosed acromegaly patients: a systematic review and meta-analysis using the GRADE system.Management of aggressive growth hormone secreting pituitary adenomas.Increased long-term remission after adequate medical cortisol suppression therapy as presurgical treatment in Cushing's disease.Preoperative lanreotide treatment improves outcome in patients with acromegaly resulting from invasive pituitary macroadenoma.Preoperative octreotide therapy and surgery in acromegaly: associations between glucose homeostasis and treatment response.Six-month preoperative octreotide treatment in unselected, de novo patients with acromegaly: effect on biochemistry, tumour volume, and postoperative cure.Daily life reflections of acromegaly guidelines.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New NomenclatureNew directions in pharmacological treatment of acromegaly
P2860
Q24647360-5A108978-80D3-4603-8E04-F3B1E9EA9714Q26741026-67DC557D-7A99-410E-92E3-AFB21173FA70Q26796357-F9211F3B-EA40-4B61-B72B-F9CCD8B3F396Q27693237-D4723CFB-4365-4D2A-8CCB-E25BB5A80EA9Q33794409-520CD6C0-B99D-4D5C-8A3E-9B1B234AAE88Q34031906-5B529C3B-BDAC-4511-8858-0110ABA04A10Q34901376-7DC75FEF-E2DA-4ED1-A289-666C42328157Q35036288-AA7D4DE7-3B36-4C0F-B2F5-3D87908179C6Q35895856-44AB799E-DE65-4DBC-99BD-4F56FD9C5506Q35943493-54C26DC4-AFD8-477F-A1F4-7C48D1E3B25FQ36860001-5A431A2F-564D-4C54-8E8D-AF91533065B4Q36919554-9B8BFF36-AFF1-4251-AE90-3A75E72F2996Q37061155-BA983983-AFB2-41FE-97BC-4FC4990BD263Q37531005-66E44E87-F0C1-481E-8ACF-46B80C69FA45Q37649647-CD76CC5C-0CFE-4193-A286-A9C85571270AQ37780553-D1CB5D8D-D1B3-4D01-86B6-829D2AAD39B2Q37798655-7D24B272-9352-443B-BC19-D773394722D8Q37859250-5A5BD89E-AFF4-462D-AEE5-C8BB502AE8BDQ37895525-BAC1B2B9-7334-41B6-A4B0-D3DE8703E7EFQ37913480-20C74EA1-9C90-4C1F-A902-51E6D44FA2C9Q37941521-DB6B9346-9A6F-4E6D-9BC1-1658F5FC07CCQ37990556-33EC7566-047E-496A-811B-2245B27A6F43Q38100275-3DDABE52-D079-4F64-A878-728C5BFBF120Q38152458-310272F4-7A2D-4B97-8805-08F817467289Q38214473-317FE7D9-8A35-4B96-982F-13762843843EQ38231413-DE5755DC-F847-4AB3-BEB3-3800B0E37B99Q38254872-DCC44811-BFB1-4D87-AA1D-208890C70F12Q38781620-717E2EB8-71B4-4354-BBED-1E4B593C8934Q44042389-8C9A46DE-1129-463D-A87F-92E5F3F1C1AFQ48500442-02BD01B9-FE86-45A3-97A5-7C4C1191F8DEQ51299912-6B5B8ECC-0C96-486D-8E3F-8CEE111FA095Q51374477-C093D83E-55B6-423B-BD5B-85308099117BQ53765411-76C8A1EA-AA7C-4363-B3F9-ED1C0AEDED95Q57144951-9F5B7B8B-D8E2-4A52-945C-65D47A757C68Q58897890-1D52F5EB-A48E-4456-888C-808D562390D6
P2860
Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Preoperative octreotide treatm ...... prospective, randomized trial.
@en
type
label
Preoperative octreotide treatm ...... prospective, randomized trial.
@en
prefLabel
Preoperative octreotide treatm ...... prospective, randomized trial.
@en
P2093
P356
P1476
Preoperative octreotide treatm ...... prospective, randomized trial.
@en
P2093
Jens Bollerslev
Johan Svartberg
John G Cooper
John K Hald
Morten Lund-Johansen
Oivind Johannesen
Preoperative Octreotide Treatment of Acromegaly study group
Stine L Fougner
Sven M Carlsen
Sylvi Aanderud
P304
P356
10.1210/JC.2008-0315
P407
P577
2008-05-20T00:00:00Z